EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H18N6 |
| Net Charge | 0 |
| Average Mass | 306.373 |
| Monoisotopic Mass | 306.15929 |
| SMILES | N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3nccc23)cn1 |
| InChI | InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1 |
| InChIKey | HFNKQEVNSGCOJV-OAHLLOKOSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiviral agent A substance that destroys or inhibits replication of viruses. antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2). |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antipsoriatic A drug used to treat psoriasis. antirheumatic drug A drug used to treat rheumatoid arthritis. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antifibrotic agent Any agent which acts to reduce fibrosis. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ruxolitinib (CHEBI:66919) has role anti-anaemic agent (CHEBI:75835) |
| ruxolitinib (CHEBI:66919) has role anti-HIV agent (CHEBI:64946) |
| ruxolitinib (CHEBI:66919) has role antifibrotic agent (CHEBI:233423) |
| ruxolitinib (CHEBI:66919) has role antimicrobial agent (CHEBI:33281) |
| ruxolitinib (CHEBI:66919) has role antineoplastic agent (CHEBI:35610) |
| ruxolitinib (CHEBI:66919) has role antipsoriatic (CHEBI:50748) |
| ruxolitinib (CHEBI:66919) has role antirheumatic drug (CHEBI:35842) |
| ruxolitinib (CHEBI:66919) has role antiviral agent (CHEBI:22587) |
| ruxolitinib (CHEBI:66919) has role dermatologic drug (CHEBI:50177) |
| ruxolitinib (CHEBI:66919) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617) |
| ruxolitinib (CHEBI:66919) has role immunosuppressive agent (CHEBI:35705) |
| ruxolitinib (CHEBI:66919) is a nitrile (CHEBI:18379) |
| ruxolitinib (CHEBI:66919) is a pyrazoles (CHEBI:26410) |
| ruxolitinib (CHEBI:66919) is a pyrrolopyrimidine (CHEBI:38670) |
| Incoming Relation(s) |
| ruxolitinib phosphate (CHEBI:66917) has part ruxolitinib (CHEBI:66919) |
| IUPAC Name |
|---|
| (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
| INN | Source |
|---|---|
| ruxolitinib | KEGG DRUG |
| Synonyms | Source |
|---|---|
| INC-424 | ChEMBL |
| INC424 | ChEMBL |
| INCB-018424 | ChEMBL |
| INCB018424 | ChemIDplus |
| INCB-18424 | ChEMBL |
| Ruxolitinib, s- | ChEMBL |
| Manual Xrefs | Databases |
|---|---|
| 4190 | DrugCentral |
| D09959 | KEGG DRUG |
| LSM-1139 | LINCS |
| Ruxolitinib | Wikipedia |
| US2008312258 | Patent |
| US2010190981 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:18703668 | Reaxys |
| CAS:941678-49-5 | KEGG DRUG |
| CAS:941678-49-5 | ChemIDplus |
| Citations |
|---|